STOCK TITAN

Encompass Health declares dividend on common stock

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
dividends
Rhea-AI Summary

Encompass Health Corp. (NYSE: EHC) has declared a quarterly cash dividend of $0.28 per share on its common stock. This dividend is payable on October 15, 2020, to shareholders on record as of October 1, 2020. As a leader in integrated healthcare services, the company operates 136 hospitals and 245 home health locations across the U.S. and Puerto Rico. Encompass Health is committed to providing high-quality, cost-effective care, showcasing its dedication to shareholder returns while maintaining a strong market position.

Positive
  • Quarterly cash dividend declared at $0.28 per share, demonstrating commitment to shareholder returns.
  • Encompass Health maintains a strong operational footprint with 136 hospitals and 245 home health locations.
Negative
  • None.

BIRMINGHAM, Ala., July 21, 2020 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.28 per share, payable on Oct. 15, 2020, to holders of record on Oct. 1, 2020.

About Encompass Health 
As a national leader in integrated healthcare services, Encompass Health (NYSE: EHC) offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. With a national footprint that includes 136 hospitals, 245 home health locations, and 83 hospice locations in 39 states and Puerto Rico, the Company is committed to delivering high-quality, cost-effective, integrated care across the healthcare continuum. Encompass Health is ranked as one of Fortune's 100 Best Companies to Work For. For more information, visit encompasshealth.com, or follow us on our newsroom, Twitter and Facebook.

Forward-Looking Statements
Statements contained in this press release which are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, the continued spread of COVID-19, including the speed, depth, geographic reach and duration of the spread, which could decrease our patient volumes and revenues and lead to staffing and supply shortages and associated cost increases; actions to be taken by Encompass Health in response to the pandemic; the legal, regulatory and administrative developments that occur at the federal, state and local levels; Encompass Health's infectious disease prevention and control efforts; Encompass Health's ability to comply with extensive, complex, and ever-changing regulations in the healthcare industry; any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings involving Encompass Health, including any matters related to yet undiscovered issues, if any, at acquired companies; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10-K for the year ended December 31, 2019 and Form 10-Q for the quarter ended March 31, 2020.

Media Contact:
Hillary Carnel | 205 970-5912
hillary.carnel@encompasshealth.com 

Investor Relations Contact:
Crissy Carlisle | 205 970-5860
crissy.carlisle@encompasshealth.com 

"Cision" View original content to download multimedia:http://www.prnewswire.com/news-releases/encompass-health-declares-dividend-on-common-stock-301097072.html

SOURCE Encompass Health Corp.

FAQ

What is the dividend amount declared by Encompass Health Corp.?

Encompass Health Corp. has declared a quarterly cash dividend of $0.28 per share.

When is Encompass Health's dividend payment date?

The dividend payment date is October 15, 2020.

Who is eligible for the Encompass Health dividend?

Shareholders on record as of October 1, 2020, are eligible for the dividend.

How often does Encompass Health declare dividends?

Encompass Health typically declares dividends on a quarterly basis.

Encompass Health Corporation

NYSE:EHC

EHC Rankings

EHC Latest News

EHC Stock Data

10.14B
100.75M
1.43%
95.58%
1.2%
Medical Care Facilities
Services-hospitals
Link
United States of America
BIRMINGHAM